Compounds > 2-n,n-di-n-propylamino-4,7-dimethoxyindan
Page last updated: 2024-09-04

2-n,n-di-n-propylamino-4,7-dimethoxyindan and preclamol

2-n,n-di-n-propylamino-4,7-dimethoxyindan has been researched along with preclamol in 1 studies

Compound Research Comparison

Studies
(2-n,n-di-n-propylamino-4,7-dimethoxyindan)		Trials
(2-n,n-di-n-propylamino-4,7-dimethoxyindan)		Recent Studies (post-2010)
(2-n,n-di-n-propylamino-4,7-dimethoxyindan)		Studies
(preclamol)		Trials
(preclamol)		Recent Studies (post-2010) (preclamol)
1600363520

Protein Interaction Comparison

ProteinTaxonomy2-n,n-di-n-propylamino-4,7-dimethoxyindan (IC50)preclamol (IC50)
D(2) dopamine receptorRattus norvegicus (Norway rat)2.0703
Sigma non-opioid intracellular receptor 1Rattus norvegicus (Norway rat)0.1599

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pinnock, RD1

Other Studies

1 other study(ies) available for 2-n,n-di-n-propylamino-4,7-dimethoxyindan and preclamol

ArticleYear
Action of putative dopamine receptor agonists, TL-99, 3-PPP and RDS-127 on substantia nigra neurons.
    Brain research, 1984, Jan-30, Volume: 292, Issue:1

    Topics: Action Potentials; Animals; Depression, Chemical; Dopamine Antagonists; Indans; Indenes; Male; Naphthalenes; Piperidines; Rats; Substantia Nigra; Tetrahydronaphthalenes

1984